1
|
Jack C, Parker C, Kouakou YE, Joubert B, McAllister KA, Ilias M, Maimela G, Chersich M, Makhanya S, Luchters S, Makanga PT, Vos E, Ebi KL, Koné B, Waljee AK, Cissé G. Leveraging data science and machine learning for urban climate adaptation in two major African cities: a HE 2AT Center study protocol. BMJ Open 2024; 14:e077529. [PMID: 38890141 PMCID: PMC11191804 DOI: 10.1136/bmjopen-2023-077529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2023] [Accepted: 05/03/2024] [Indexed: 06/20/2024] Open
Abstract
INTRODUCTION African cities, particularly Abidjan and Johannesburg, face challenges of rapid urban growth, informality and strained health services, compounded by increasing temperatures due to climate change. This study aims to understand the complexities of heat-related health impacts in these cities. The objectives are: (1) mapping intraurban heat risk and exposure using health, socioeconomic, climate and satellite imagery data; (2) creating a stratified heat-health forecast model to predict adverse health outcomes; and (3) establishing an early warning system for timely heatwave alerts. The ultimate goal is to foster climate-resilient African cities, protecting disproportionately affected populations from heat hazards. METHODS AND ANALYSIS The research will acquire health-related datasets from eligible adult clinical trials or cohort studies conducted in Johannesburg and Abidjan between 2000 and 2022. Additional data will be collected, including socioeconomic, climate datasets and satellite imagery. These resources will aid in mapping heat hazards and quantifying heat-health exposure, the extent of elevated risk and morbidity. Outcomes will be determined using advanced data analysis methods, including statistical evaluation, machine learning and deep learning techniques. ETHICS AND DISSEMINATION The study has been approved by the Wits Human Research Ethics Committee (reference no: 220606). Data management will follow approved procedures. The results will be disseminated through workshops, community forums, conferences and publications. Data deposition and curation plans will be established in line with ethical and safety considerations.
Collapse
Affiliation(s)
- Christopher Jack
- Climate System Analysis Group, University of Cape Town, Rondebosch, Western Cape, South Africa
| | - Craig Parker
- Wits Planetary Health Research, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Yao Etienne Kouakou
- University Peleforo Gon Coulibaly, Korhogo, Côte d'Ivoire
- Centre Suisse de Recherches Scientifiques, Abidjan, Côte d'Ivoire
| | - Bonnie Joubert
- National Institute of Environmental Health Sciences, Durham, North Carolina, USA
| | | | - Maliha Ilias
- National Heart Lung and Blood Institute, Bethesda, Maryland, USA
| | - Gloria Maimela
- Climate and Health Directorate, Wits Reproductive Health and HIV Institute, Hillbrow, Gauteng, South Africa
| | - Matthew Chersich
- Wits Planetary Health Research, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- Public Health and Primary Care, School of Medicine, Trinity College Dublin, Dublin, UK
| | | | - Stanley Luchters
- Centre for Sexual Health and HIV & AIDS Research (CeSHHAR), Harare, Zimbabwe
- Liverpool School of Tropical Medicine, Liverpool, UK
| | - Prestige Tatenda Makanga
- Centre for Sexual Health and HIV & AIDS Research (CeSHHAR), Harare, Zimbabwe
- Surveying and Geomatics Department, Midlands State University, Gweru, Zimbabwe
| | - Etienne Vos
- IBM Research-Africa, Johannesburg, South Africa
| | | | - Brama Koné
- University Peleforo Gon Coulibaly, Korhogo, Côte d'Ivoire
- Centre Suisse de Recherches Scientifiques, Abidjan, Côte d'Ivoire
| | - Akbar K Waljee
- Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA
- Ann Arbor VA Medical Center, VA Center for Clinical Management Research, Ann Arbor, Michigan, USA
| | - Guéladio Cissé
- University Peleforo Gon Coulibaly, Korhogo, Côte d'Ivoire
- Centre Suisse de Recherches Scientifiques, Abidjan, Côte d'Ivoire
| |
Collapse
|
2
|
Giannakeas V, Sopik V, Narod S. A Validation of Methods for the Evaluation of Observational Studies of Screening Mammography: An Exploratory Analysis Based on Simulating Screening Cohorts. Clin Epidemiol 2020; 12:1161-1169. [PMID: 33149693 PMCID: PMC7602915 DOI: 10.2147/clep.s267584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Accepted: 09/30/2020] [Indexed: 12/05/2022] Open
Abstract
Background The degree of confidence one should place on non-randomised observational trials studies which estimate the benefit of screening depends on the validity of the analytic method employed. As is the case for all observational trials, screening evaluation studies are subject to bias. The objective of this study was to create a simulated data set and to compare four analytic methods in order to identify the method which was the least biased in terms of estimating the underlying hazard ratio. Methods We simulated a cohort of 100,000 women who were accorded US national rates of breast cancer incidence and breast cancer mortality over their lifetime. We assigned at random one-half of them to initiate mammography screening between ages 50 and 60. We used four different analytic approaches to estimate the hazard ratio under a null model (true HR = 1.0) and under a protective model (true HR = 0.80). Two models used the entire data set (with and without including mammography as a time-dependent covariate) and two models invoked matching of screened women with unscreened women (with and without excluding of women who had a mammogram after study initiation). For each of the four analytic methods, we compared the observed hazard ratio with the true hazard ratio. We considered an analytic method to be valid if the observed hazard ratio was close to the true hazard ratio. Results Two simple analytic methods generated biased results that led to spurious protective effects observed when none was there. The least biased method was based on matching screened and unscreened women and which emulated a randomized trial design, wherein the unexposed control had no mammogram prior to study entry, but she was not excluded or censored if she had a mammogram after the index date. Conclusion There is no single ideal method to analyze observational data to evaluate the effectiveness of screening mammography (ie, which generates an unbiased estimates of the underlying hazard ratio) but designs which emulate randomised trials should be promoted.
Collapse
Affiliation(s)
- Vasily Giannakeas
- Women's College Research Institute, Toronto, Ontario, Canada.,Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Victoria Sopik
- Women's College Research Institute, Toronto, Ontario, Canada.,Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
| | - Steven Narod
- Women's College Research Institute, Toronto, Ontario, Canada.,Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.,Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|
3
|
Narod SA, Giannakeas V. In Response to "Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations". J Clin Oncol 2020; 38:4352. [PMID: 33125308 DOI: 10.1200/jco.20.02253] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Steven A Narod
- Steven A. Narod, MD, and Vasily Giannakeas, MPH, Dalla Lana School of Public Health, University of Toronto; and Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada
| | - Vasily Giannakeas
- Steven A. Narod, MD, and Vasily Giannakeas, MPH, Dalla Lana School of Public Health, University of Toronto; and Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada
| |
Collapse
|